Skip to main content

Elevated Levels of the P53 Tumour Suppressor Protein in the Basal Layer of Recurrent Laryngeal Papillomas

  • Chapter
Immunology of Human Papillomaviruses

Abstract

A viral aetiology for recurrent respiratory papillomatosis (RRP) has long since been postulated and the human papilloma virus (HPV) types 6,11,16 and 18 have been detected reproducibly in laryngeal papillomas and squamous cell carcinomas of the head and neck (SCCs of the H & N). Whilst the underlying mechanism(s) for the abnormal proliferation of respiratory epithelial cells leading to the formation of papillomas is unknown, it is known that the above HPV types, transform keratinocytes in culture with potencies which correlate with their ability to inactivate the p53 tumour suppressor protein. The E6 proteins of HPVs 16 and 18 complex and degrade the p53 protein1,2, whereas HPV6 and 11 E6 proteins have been reported to only weakly bind p53 without degradation2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Scheffner, B.A. Werness, J.M. Humbregtse, A.J. Levine and P.M. Howley, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell 63:1129 (1990).

    Article  PubMed  CAS  Google Scholar 

  2. T. Crook, J.A. Tidy and K.H. Vousden, Degradation of p53 can be targeted by HPV sequences distinct from those required for p53 binding and trans-activation, Cell 67:547 (1991).

    Article  PubMed  CAS  Google Scholar 

  3. J.E. Burns, M.C. Baird, L.J. Clark, P. Burns, K. Edington, C. Chapman, R. Mitchell, G. Robertson, D. Soutar and E.K. Parkinson, Gene mutations and elevated protein levels in human squamous cell carcinomas and their cell lines, Br J Cancer 67:1274 (1993).

    Article  PubMed  CAS  Google Scholar 

  4. M.J. Arends, Y.K. Donaldson, E. Duvall, A.H. Wyllie and C. Bird, HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method, J Pathol 165:301 (1991).

    Article  PubMed  CAS  Google Scholar 

  5. G.R. Ogden, R.A. Kiddie, D.P Lunny and D.A. Lane, Assessment of p53 protein in normal, benign and malignant oral mucosa, J Pathol. 166:389 (1992).

    Article  PubMed  CAS  Google Scholar 

  6. S.W. Lowe and H. Ruley, Stabilization of the p53 tumor suppressor is induced by adenovirus 5 El A and accompanies apoptosis, Gene Devel 7:535 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Clark, L.J., MacKenzie, K., Parkinson, E.K. (1994). Elevated Levels of the P53 Tumour Suppressor Protein in the Basal Layer of Recurrent Laryngeal Papillomas. In: Stanley, M.A. (eds) Immunology of Human Papillomaviruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2449-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2449-6_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6041-4

  • Online ISBN: 978-1-4615-2449-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics